BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Al Dhibi HA, Arevalo JF. Clinical trials on corticosteroids for diabetic macular edema. World J Diabetes 2013; 4(6): 295-302 [PMID: 24379920 DOI: 10.4239/wjd.v4.i6.295]
URL: https://www.wjgnet.com/1948-9358/full/v4/i6/295.htm
Number Citing Articles
1
Mücella Arıkan Yorgun, Yasin Toklu, Melek Mutlu, Betül Seher Uysal, Hasan Basri Çakmak. Efficacy of single-dose dexamethasone implantation in patients with persistent diabetic macular edemaInternational Ophthalmology 2016; 36(4): 531 doi: 10.1007/s10792-015-0155-6
2
Yanan Zhu, Chaohui Sun, Xin Zhang, Xingchao Shentu. Ptosis induced by topical steroid eye dropsMedicine 2017; 96(51): e9288 doi: 10.1097/MD.0000000000009288
3
Mohammad Ali Sadiq, Aniruddha Agarwal, Mohamed K Soliman, Mostafa Hanout, Salman Sarwar, Diana V Do, Quan Dong Nguyen. Sustained-release fluocinolone acetonide intravitreal insert for macular edema: clinical pharmacology and safety evaluationExpert Opinion on Drug Safety 2015; 14(7): 1147 doi: 10.1517/14740338.2015.1041916
4
Elizabeth A. Atchison, Sophie J. Bakri. Intraocular Pressure after Intravitreal Triesence InjectionSeminars in Ophthalmology 2018; 33(3): 308 doi: 10.1080/08820538.2016.1229341
5
Stefano Fogli, Selene Mogavero, Colin Gerard Egan, Marzia Del Re, Romano Danesi. Pathophysiology and pharmacological targets of VEGF in diabetic macular edemaPharmacological Research 2016; 103: 149 doi: 10.1016/j.phrs.2015.11.003
6
José Juan Escobar-Barranco, Begoña Pina-Marín, Manel Fernández-Bonet. Dexamethasone Implants in Patients with Naïve or Refractory Diffuse Diabetic Macular EdemaOphthalmologica 2015; 233(3-4): 176 doi: 10.1159/000371770
7
Enzhong Jin, Ling Luo, Yujing Bai, Mingwei Zhao. Comparative Effectiveness of Intravitreal Bevacizumab With or Without Triamcinolone Acetonide for Treatment of Diabetic Macular EdemaAnnals of Pharmacotherapy 2015; 49(4): 387 doi: 10.1177/1060028014568006
8
Giuseppe Lo Giudice, Antonio Avarello, Gianluca Campana, Alessandro Galan. Rapid response to dexamethasone intravitreal implant in diabetic macular edemaEuropean Journal of Ophthalmology 2018; 28(1): 74 doi: 10.5301/ejo.5000989
9
Sukhvinder Singh, Pawan Kumar Singh, Zeeshan Ahmad, Susmita Das, Marc Foretz, Benoit Viollet, Shailendra Giri, Ashok Kumar. Myeloid Cell–Specific Deletion of AMPKα1 Worsens Ocular Bacterial Infection by Skewing Macrophage Phenotypes The Journal of Immunology 2024; 213(11): 1656 doi: 10.4049/jimmunol.2400282
10
Vanessa Andrés-Guerrero, Irene Bravo-Osuna, Pilar Pastoriza, Irene T. Molina-Martinez, Rocío Herrero-Vanrell. Novel technologies for the delivery of ocular therapeutics in glaucomaJournal of Drug Delivery Science and Technology 2017; 42: 181 doi: 10.1016/j.jddst.2017.07.001
11
Mihir Shah, Sara Cabrera-Ghayouri, Lori-Ann Christie, Katherine S. Held, Veena Viswanath. Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug DevelopmentPharmaceutical Research 2019; 36(4) doi: 10.1007/s11095-019-2588-5
12
Mari Pesonen, Eila Kankaanpää, Pasi Vottonen. Cost‐effectiveness of dexamethasone and triamcinolone for the treatment of diabetic macular oedema in Finland: A Markov‐modelActa Ophthalmologica 2021; 99(7) doi: 10.1111/aos.14745
13
Amin Hatamnejad, Samantha Orr, Rohan Dadak, Arshad Khanani, Rishi Singh, Netan Choudhry. Anti‐VEGF and steroid combination therapy relative to anti‐VEGF mono therapy for the treatment of refractory DME: A systematic review of efficacy and meta‐analysis of safetyActa Ophthalmologica 2024; 102(3) doi: 10.1111/aos.15724
14
Angelo Maria Minnella, Martina Maceroni, Stefano Maria Picardi, Giorgio Placidi, Elisa De Siena, Stanislao Rizzo, Benedetto Falsini. Combined Intravitreal Dexamethasone Implant and Cataract Surgery in Patients with Diabetic Retinopathy: Effect on Retinal Morphology and FunctionAdvances in Therapy 2020; 37(11): 4675 doi: 10.1007/s12325-020-01506-8
15
Bozho Todorich, Tamer H. Mahmoud. Vitrectomy for Diabetic Macular EdemaCurrent Ophthalmology Reports 2014; 2(4): 167 doi: 10.1007/s40135-014-0052-6
16
Focke Ziemssen, Hansjürgen T. Agostini. Anti-Angiogenic Therapy in OphthalmologyEssentials in Ophthalmology 2016; : 89 doi: 10.1007/978-3-319-24097-8_6
17
Patricia Udaondo, Ana Hervas-Ontiveros, Amir Rosemblatt, Salvador Garcia-Delpech. Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® OutcomesClinical Ophthalmology 2021; : 4153 doi: 10.2147/OPTH.S336865
18
Claudio Bucolo, Giuseppe Grosso, Valentina Drago, Caterina Gagliano. Intravitreal Triamcinolone Acetonide in the Treatment of Ophthalmic Inflammatory Diseases with Macular Edema: A Meta-Analysis StudyJournal of Ocular Pharmacology and Therapeutics 2015; 31(4): 228 doi: 10.1089/jop.2014.0094
19
Sadık Görkem Çevik, Sami Yılmaz, Mediha Tok Çevik, Fatma Düriye Akalp, Remzi Avcı. Comparison of the Effect of Intravitreal Dexamethasone Implant in Vitrectomized and Nonvitrectomized Eyes for the Treatment of Diabetic Macular EdemaJournal of Ophthalmology 2018; 2018: 1 doi: 10.1155/2018/1757494
20
Francesco Boscia, Daniele Veritti, Cristiana Iaculli, Rosangela Lattanzio, Simona Freda, Benedetta Piergentili, Monica Varano. Management of treatment-naïve diabetic macular edema patients: Review of real-world clinical dataEuropean Journal of Ophthalmology 2024; 34(6): 1675 doi: 10.1177/11206721241237069